Moderna: Third coronavirus vaccine approved for use in the UK

A third vaccine has been approved for use in the UK.

The jab, developed by US-based company Moderna, has been shown to have a 94 per cent effectiveness against Covid-19.

The UK Government has ordered seven million doses of the new vaccine, with 10 million more to arrive by March.

The staggered roll-out is understood to be caused by the fact that while Moderna has manufacturing plants in Europe, they are not yet ready to begin distribution.

The jab, developed by US-based company Moderna, has been shown to have a 94 per cent effectiveness against Covid-19.

The drug, which was first approved in the United States, where the Food and Drug Administration (FDA) examined the results of a 30,000-volunteer study.

The UK was the first country in the world to approve the Pfizer/BioNTech vaccine, and has since also begun rollout of the Oxford/AstraZeneca jab.

Statistics released on Thursday revealed that 1.26 million jabs had been given in England, 113,000 in Scotland, 49,000 in Wales, and 46,000 in Northern Ireland.

A message from the Editor:

Thank you for reading this article. We're more reliant on your support than ever as the shift in consumer habits brought about by coronavirus impacts our advertisers.

If you haven't already, please consider supporting our trusted, fact-checked journalism by taking out a digital subscription.